ACADIA Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
ACADIA Pharmaceuticals has a total shareholder equity of $577.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $976.9M and $399.7M respectively. ACADIA Pharmaceuticals's EBIT is $112.2M making its interest coverage ratio -4.8. It has cash and short-term investments of $565.3M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -4.8x |
| Cash | US$565.33m |
| Equity | US$577.18m |
| Total liabilities | US$399.69m |
| Total assets | US$976.87m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A4W's short term assets ($788.3M) exceed its short term liabilities ($343.9M).
Long Term Liabilities: 0A4W's short term assets ($788.3M) exceed its long term liabilities ($55.7M).
Debt to Equity History and Analysis
Debt Level: 0A4W is debt free.
Reducing Debt: 0A4W has not had any debt for past 5 years.
Debt Coverage: 0A4W has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 0A4W has no debt, therefore coverage of interest payments is not a concern.